Concepedia

Charles Harper

CH

8

Publications

889

Citations

8

H-Index

1987

Active since

Affiliations

Moderna Therapeutics (United States)(Current)

Brigham and Women's Hospital

Meridian Clinical Research

Charles Harper is an author at Moderna Therapeutics (United States) specializing in medicine, vaccine development, and broad-spectrum vaccines.

Top concepts

Publications per year

1987–2024

8

Publications

8

A Bivalent Omicron-Containing Booster Vaccine against Covid-19

Spyros Chalkias, Charles Harper, Keith Vrbicky et al. · New England Journal of Medicine · 2022 · 638 citations · Full text

A Bivalent Omicron-containing Booster Vaccine Against Covid-19

Spyros Chalkias, Charles Harper, Keith Vrbicky et al. · 2022 · 76 citations · Full text

, , +14

Capillary gas chromatographic-electron capture detection of coca-leaf-related impurities in illicit cocaine: 2,4-diphenylcyclobutane-1,3-dicarboxylic acids, 1,4-diphenylcyclobutane-2,3-dicarboxylic acids and their alkaloidal precursors, the truxillines

James M. Moore, Donald A. Cooper, Ira S. Lurie et al. · Journal of Chromatography A · 1987 · 51 citations

, , +11

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults

Christine A. Shaw, Brandon Essink, Charles Harper et al. · The Journal of Infectious Diseases · 2024 · 50 citations · Full text

Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19

Spyros Chalkias, Charles Harper, Keith Vrbicky et al. · Nature Communications · 2023 · 27 citations · Full text

Rows per page

1–5 of 8